Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial (Q34611762)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial |
scientific article |
Statements
1 reference
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial (English)
1 reference
Hans-Peter Hartung
1 reference
Ludwig Kappos
1 reference
Frederik Barkhof
1 reference
David H Miller
1 reference
Chris H Polman
1 reference
Mark S Freedman
1 reference
Gilles Edan
1 reference
Xavier Montalbán
1 reference
Ernst-Wilhelm Radü
1 reference
Carola Metzig
1 reference
Lars Bauer
1 reference
Vivian Lanius
1 reference
Rupert Sandbrink
1 reference
Christoph Pohl
1 reference
BENEFIT Study Group
1 reference
10 September 2009
1 reference
1 reference
Identifiers
1 reference